NNNN
Anbio Biotechnology
NASDAQ · Healthcare · Medical - Instruments & Supplies · DE
$5.25
−6.25%Institutional positioning
13F filings over the trailing two quarters
New 9Increased 5Reduced 3Sold out 2
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 26,736 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 25,763 | May 15, 2026 |
| BANK OF AMERICA CORP /DE/ | New Position | 13,419 | Aug 14, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | Increased | 11,800 | Aug 13, 2026 |
| MARSHALL WACE, LLP | New Position | 11,502 | Aug 13, 2026 |
| BNP PARIBAS ARBITRAGE, SNC | Increased | 10,400 | May 12, 2026 |
| MORGAN STANLEY | Increased | 7,338 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 7,231 | Aug 13, 2026 |
| UBS GROUP AG | Increased | 6,339 | May 5, 2026 |
| UBS Group AG | Reduced | 828 | Aug 13, 2026 |
| EVERSOURCE WEALTH ADVISORS, LLC | New Position | 266 | May 18, 2026 |
| EverSource Wealth Advisors, LLC | Reduced | 187 | Jul 24, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 100 | Jul 8, 2026 |
| OSAIC HOLDINGS, INC. | New Position | 77 | Aug 14, 2026 |
| JPMORGAN CHASE & CO | New Position | 53 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings